Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASC30 in Adult Participants With Obesity or Overweight (AURORA-1)
NCT07743463Phase 3Recruiting
- Sponsor
- Ascletis Pharma Inc.
- Start
- Aug 2026
- Primary completion
- Jul 2028
- Countries
- 7
01
Overview
A Phase 3 trial of ASC30 in obesity, Overweight, sponsored by Ascletis Pharma Inc.. Started Aug 2026; status: recruiting.
02
Drugs
ASC30
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT07743463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07743463.